Protocols in Heart and Lung Transplantation: An Essential Guide to Preoperative Assessment and Timing to Improve Outcomes

2004 ◽  
Vol 3 (1) ◽  
pp. 20-25
Author(s):  
Victor Tapson ◽  
Robert Frantz ◽  
John Conte
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Critical Care ◽  
Lung Transplantation ◽  
Medical Center ◽  
Preoperative Assessment ◽  
Assistant Professor ◽  
Associate Professor ◽  
Johns Hopkins University ◽  
Duke University

This discussion was moderated by Victor Tapson, MD, Editor-in-Chief of Advances in Pulmonary Hypertension and Associate Professor, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina. The participants included Robert Frantz, MD, Assistant Professor of Medicine, Cardiovascular Division, Mayo Clinic, Rochester, Minnesota; and John Conte, MD, Associate Professor of Surgery and Director of Heart and Lung Transplantation, Johns Hopkins University, Baltimore, MD.

scholarly journals Meeting the Challenge of Surgery and Pulmonary Hypertension: How to Manage the “Hemodynamic Environment” to Optimize Outcomes

2007 ◽  
Vol 6 (2) ◽  
pp. 92-95
Author(s):  
Richard Channick ◽  
Kenneth R. McCurry ◽  
Ronald Pearl ◽  
Stuart Rich
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
Lung Transplantation ◽  
San Diego ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
University Of California ◽  
University Of Pittsburgh ◽  
School Of Medicine

This discussion was moderated by Richard Chan-nick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. Panel members included Kenneth R. McCurry, MD, Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Director, Lung and Heart-Lung Transplantation Programs, University of Pittsburgh Department of Surgery, Pittsburgh, Pennsylvania; Ronald Pearl, MD, PhD, Professor and Chair, Anesthesia Department, Stanford University School of Medicine, Stanford, California; and Stuart Rich, MD, Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, Illinois.

Pulmonary Hypertension Roundtable: Recapping 5 Years, Exploring Emerging Approaches

2006 ◽  
Vol 5 (4) ◽  
pp. 32-39 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
Richard N. Channick ◽  
Ivan M. Robbins ◽  
Victor F. Tapson
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Critical Care ◽  
San Diego ◽  
Medical Center ◽  
Associate Professor ◽  
University Of Michigan ◽  
Ann Arbor ◽  
Duke University ◽  
Vanderbilt University

This discussion was moderated by Vallerie V. McLaughlin, MD, Associate Professor of Medicine and Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan. Panel members included Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Ivan M. Robbins, MD, Director of the Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee; and Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.

scholarly journals Recapping Highlights from Pulmonary Hypertension Association Scientific Sessions and Identifying Key Issues Driving Translational Research

2004 ◽  
Vol 3 (3) ◽  
pp. 23-27
Author(s):  
Michael McGoon ◽  
Victor F. Tapson ◽  
Richard N. Channick ◽  
Valerie V. McLaughlin ◽  
Ronald J. Oudiz ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
San Diego ◽  
Medical Center ◽  
Associate Professor ◽  
University Of Michigan ◽  
School Of Medicine ◽  
Ann Arbor ◽  
Duke University ◽  
Key Issues

This discussion was moderated by Michael McGoon, MD, Professor of Medicine and Consultant in the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota. Participants included members of the Editorial Advisory Board of Advances in Pulmonary Hypertension: Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, and Editor-in-Chief of the journal; Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Vallerie V. McLaughlin, MD, Associate Professor of Medicine, Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan; Ronald J. Oudiz, MD, Associate Professor of Medicine, UCLA School of Medicine, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California; and Ivan M. Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee.

scholarly journals Pulmonary Hypertension Roundtable

2005 ◽  
Vol 4 (2) ◽  
pp. 24-29
Author(s):  
Richard Channick ◽  
Hap Farber ◽  
Nicholas Hill ◽  
Robert Schilz
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
New England ◽  
San Diego ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
University Of California ◽  
Boston University ◽  
England Medical

This discussion was moderated by Richard Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California. The physicians participating included Hap Farber, MD, Director, Pulmonary Hypertension Center, Boston University Medical Center, Boston, Massachusetts; Nicholas Hill, MD, Chief, Pulmonary, Critical Care and Sleep Division, Tufts-New England Medical Center, Boston, Massachusetts; and Robert Schilz, PhD, DO, Director of Lung Transplantation and Advanced Lung Disease, and Assistant Professor of Medicine, Case Western Reserve University, Cleveland, Ohio.

scholarly journals Pulmonary Hypertension Roundtable

2005 ◽  
Vol 4 (3) ◽  
pp. 26-30 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
Richard N. Channick ◽  
Ivan M. Robbins ◽  
Victor F. Tapson
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
San Diego ◽  
Medical Center ◽  
Associate Professor ◽  
Response To Therapy ◽  
University Of Michigan ◽  
Ann Arbor ◽  
Thromboembolic Pulmonary Hypertension ◽  
Duke University

In this discussion four experts shared insights on what might be considered the “gestalt” of diagnosing and monitoring pulmonary arterial hypertension. They ranged over a broad spectrum of issues that included thromboembolic pulmonary hypertension, exercise testing, hemodynamics, imaging studies, and response to therapy. The discussion was moderated by Vallerie V. McLaughlin, MD, Associate Professor of Medicine, Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan. The participants included Richard N. Channick, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Ivan M. Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee; and Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.

scholarly journals Imatinib: A Perspective on Its Potential for PAH Patients

2012 ◽  
Vol 11 (1) ◽  
pp. 41-46
Author(s):  
R. James White ◽  
Mardi Gomberg-Maitland ◽  
Jeremy Feldman ◽  
Ioana Preston ◽  
Steve Mathai
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Phase Iii ◽  
Recent Phase ◽  
Hemodynamic Impairment ◽  
Pulmonary Arterial

We invited 4 experts to a telephone roundtable facilitated by guest editor Jim White, MD, PhD, on April 13, 2012, to discuss the results of the recent Phase III trial, the Imatinib in Pulmonary Arterial Hypertension (IMPRES) trial (NCT00902174). Investigators enrolled patients with pulmonary arterial hypertension with severe hemodynamic impairment at catheterization despite treatment with 2 background therapies. Patients were randomized to placebo or 200 mg imatinib twice daily for 6 months of therapy to assess efficacy. Participating in the discussion were Mardi Gomberg-Maitland, MD, MSc, Associate Professor of Medicine and Director, Pulmonary Hypertension Center, University of Chicago; Iona Preston, MD, Co-director, Pulmonary Hypertension Center, Tufts University Medical Center, Boston; Jeremy Feldman, MD, Director, Pulmonary Hypertension Program, Medical Director of Research, Arizona Pulmonary Specialists, Phoenix; Stephen Mathai, MD, MHS, Assistant Professor of Medicine, The Johns Hopkins School of Medicine, Baltimore.

Assisting Pulmonary Hypertension Patients and Families With Treatment Decisions

2010 ◽  
Vol 8 (4) ◽  
pp. 239-243
Author(s):  
Karen Frutiger ◽  
Martha Kingman ◽  
Abby Poms ◽  
Glenna Traiger
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Los Angeles ◽  
Medical Center ◽  
Pulmonary Vascular Disease ◽  
University Of Texas ◽  
Program Manager ◽  
Nurse Coordinator ◽  
Duke University ◽  
Pulmonary Arterial

To complement this issue's theme, “Living With Pulmonary Hypertension,” a discussion on assisting patients with therapy decisions was led by guest editor Glenna Traiger, RN, MSN, Pulmonary Hypertension CNS, University of California, Los Angeles. The panelists included Karen Frutiger, RN, Clinical Nurse Coordinator, University of Rochester Pulmonary Arterial Hypertension Program, Rochester, NY; Martha Kingman, Nurse Practitioner, University of Texas Southwestern Medical Center, Dallas; and Abby Poms, RRT, Duke University Pulmonary Vascular Disease Program Manager, Duke University Medical Center, Durham, North Carolina.

Pulmonary Hypertension Roundtable: Perspectives on PHA's 10th International PH Conference

2012 ◽  
Vol 11 (3) ◽  
pp. 135-140
Keyword(s):  
Pulmonary Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Medical Director ◽  
Pulmonary Vascular Disease ◽  
University Of Utah ◽  
University Of Colorado ◽  
Assistant Director ◽  
Vanderbilt University

As a way to integrate the presentations at PHA's June scientific sessions with clinical practice, Guest Editor Karen Fagan, MD, convened a group of attendees to discuss their experience in Orlando. The discussants included Todd Bull, MD, Associate Professor, Medical Director, Anschutz Intensive Care Unit, University of Colorado, Aurora, Colorado; Anna Hemnes, MD, Assistant Director, Center for Adult Pulmonary Vascular Disease, Vanderbilt University, Nashville, Tennessee; C. Gregory Elliott, MD, Professor of Medicine, University of Utah and Medical Director, Pulmonary Hypertension Center, Intermountain Medical Center, Murray, Utah; Vinicio A. de Jesus Perez, MD, Assistant Professor in Medicine and Staff Physician, Wall Center Adult PH Clinic, Stanford University Medical Center, Palo Alto, California; and Paul B. Yu, MD, PhD, Brigham and Women's Hospital, Boston, Massachusetts.

scholarly journals PH Roundtable: Pulmonary Hypertension Roundtable: Clinical Experiences With Drug- and Toxin-Related PH

2018 ◽  
Vol 17 (2) ◽  
pp. 80-85
Keyword(s):  
Pulmonary Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Texas Southwestern Medical ◽  
Clinical Experiences ◽  
University Of Texas ◽  
School Of Medicine ◽  
Hypertension Clinic ◽  
The University

Sonja Bartolome, MD, pulmonary hypertension specialist and Director of Liver Transplant Critical Care at University of Texas Southwestern Medical Center, Dallas, facilitated a comprehensive discussion among 4 additional clinical experts regarding their experiences with the broad-ranging issues related to treating patients with drug- and toxin-related pulmonary hypertension. Joining the call on May 3, 2018, were Vinicio de Jesus Perez, MD, Assistant Professor of Medicine and staff physician and Roham Zamanian, MD, Associate Professor of Medicine and Medical Director, from the Pulmonary Hypertension Clinic at Stanford University School of Medicine; Kelly Chin, MD, Director of the Pulmonary Hypertension Center at University of Texas Southwestern Medical Center; and Konstadina Darsaklis, MD, Assistant Professor at the University of Connecticut, and cardiologist at Hartford Hospital where she started the pulmonary hypertension clinic.

scholarly journals Expanded Use of PAH Medications

2008 ◽  
Vol 7 (1) ◽  
pp. 249-254
Author(s):  
Karen A. Fagan ◽  
Kamal K. Mubarak ◽  
Zeenat Safdar ◽  
Aaron Waxman ◽  
Roham T. Zamanian
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
Vascular Disease ◽  
Massachusetts General Hospital ◽  
Assistant Professor ◽  
Associate Professor ◽  
Pulmonary Vascular Disease ◽  
Pulmonary Medicine ◽  
State University ◽  
Wayne State University

This discussion was moderated by Karen A. Fagan, MD, Professor and Director, Division of Pulmonary Medicine, University of South Alabama College of Medicine, Mobile, Alabama. Panel members included Kamal K. Mubarak, MD, Assistant Professor of Medicine, Director, Pulmonary Hypertension Clinic, Wayne State University, Detroit, Michigan; Zeenat Safdar, MD, Assistant Professor of Medicine, Department of Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, Texas; Aaron Waxman, MD, PhD, Associate Professor of Medicine, Harvard Medical School, Director, Pulmonary Vascular Disease Program and Pulmonary Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts; and Roham T. Zamanian, MD, Assistant Professor of Medicine, Director, Adult Pulmonary Hypertension Clinical Service, Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University School of Medicine, Stanford, California.

Sign in / Sign up

Export Citation Format

Share Document